Articles published by LAVA Therapeutics N.V.
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
March 20, 2024
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
November 16, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
August 22, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
August 14, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
June 08, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Announces Appointment of Christy J. Oliger to its Board of Directors
March 09, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference
February 09, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Announces the Appointment of Dr. Charles Morris as Chief Medical Officer
February 06, 2023
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results
November 16, 2022
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
Via GlobeNewswire
Tickers
LVTX
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/4759b844-227f-4632-b22d-4fe63fad55b4/small/lavatx-rgb-jpg.jpg)
LAVA Therapeutics Announces Appointment of Fred M. Powell as Chief Financial Officer
November 01, 2022
Via GlobeNewswire
Tickers
LVTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.